Thyrocare Technologies IPO is a book build issue of ₹479.21 crores. The issue is entirely an offer for sale of 1.07 crore shares of ₹479.21 crore.
Thyrocare Technologies IPO bidding started from Apr 27, 2016 and ended on Apr 29, 2016. The shares got listed on BSE, NSE on May 9, 2016.
Thyrocare Technologies IPO price band is set at ₹446.00 per share . The lot size for an application is 33. The minimum amount of investment required by an retail is ₹13,860 (33 shares). The lot size investment for sNII is 14 lots (462 shares), amounting to ₹2,06,052, and for bNII, it is 68 lots (2,244 shares), amounting to ₹10,00,824.
Edelweiss Financial Services Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Thyrocare Technologies IPO RHP for detailed Information.
IPO Date | April 27, 2016 to April 29, 2016 |
Listing Date | May 9, 2016 |
Face Value | ₹10 per share |
Issue Price Band | ₹420 to ₹446 per share |
Issue Price Final | ₹446 per share |
Lot Size | 33 Shares |
Sale Type | Offer For Sale |
Total Issue Size | 1,07,44,708 shares (aggregating up to ₹479.21 Cr) |
Issue Type | Bookbuilding IPO |
Listing At | BSE, NSE |
Share Holding Pre Issue | 5,37,23,533 shares |
Share Holding Post Issue | 5,37,23,533 shares |
Thyrocare Technologies IPO offers total 1,07,44,708 shares. Out of which 53,72,353 (50.00%) allocated to QIB, 21,48,942 (20.00%) allocated to QIB, 16,11,707 (15.00%) allocated to NII, 37,60,648 (35.00%) allocated to RII and 32,23,411 (30.00%) allocated to Anchor investors.
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
QIB Shares Offered | 53,72,353 (50.00%) | NA |
− Anchor Investor Shares Offered | 32,23,411 (30.00%) | NA |
− QIB (Ex. Anchor) Shares Offered | 21,48,942 (20.00%) | NA |
NII (HNI) Shares Offered | 16,11,707 (15.00%) | NA |
Retail Shares Offered | 37,60,648 (35.00%) | 1,13,959 |
Total Shares Offered | 1,07,44,708 (100.00%) |
Thyrocare Technologies IPO opens on April 27, 2016, and closes on April 29, 2016.
IPO Open Date | Wed, Apr 27, 2016 |
IPO Close Date | Fri, Apr 29, 2016 |
Tentative Listing Date | Mon, May 9, 2016 |
Cut-off time for UPI mandate confirmation | 5 PM on Fri, Apr 29, 2016 |
Investors can bid for a minimum of 33 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 33 | ₹14,718 |
Retail (Max) | 13 | 429 | ₹1,91,334 |
S-HNI (Min) | 14 | 462 | ₹2,06,052 |
S-HNI (Max) | 67 | 2,211 | ₹9,86,106 |
B-HNI (Min) | 68 | 2,244 | ₹10,00,824 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.
They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.
Particulars |
For the year/period ended (in Rs. Million) | |
31-Dec-15 | 31-Mar-15 | |
Total Revenue | 1,804.73 | 1,903.38 |
Profit After Tax (PAT) | 400.21 | 432.54 |
KPI | Values |
---|---|
RoNW | 17.37% |
[Dilip Davda] <p><strong><u>Considering the brand image and the operational methods, the company is poised for bright prospects ahead. Investment in this IPO will bring reasonable rewards in coming years. Investment may be considered for short to long term.</u></strong></p> Read detail review...
Listing Date | May 9, 2016 |
BSE Script Code | 539871 |
NSE Symbol | THYROCARE |
ISIN | INE594H01019 |
Final Issue Price | ₹446 per share |
BSE Listing Group | B |
Thyrocare Technologies Ltd.
D/37-1, TTC Industrial Area
MIDC Turbhe,
Navi Mumbai 400 703
Navi Mumbai, Maharashtra
Phone: +(91 22) 2762 2762
Email: ramjee.d@thyrocare.com
Website: http://www.thyrocare.com
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: ttl.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Thyrocare Technologies IPO is a main-board IPO of 1,07,44,708 equity shares of the face value of ₹10 aggregating up to ₹479.21 Crores. The issue is priced at ₹446 per share. The minimum order quantity is 33.
The IPO opens on April 27, 2016, and closes on April 29, 2016.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Thyrocare Technologies IPO using UPI as a payment gateway. Zerodha customers can apply in Thyrocare Technologies IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Thyrocare Technologies IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Thyrocare Technologies IPO opens on April 27, 2016 and closes on April 29, 2016.
Thyrocare Technologies IPO lot size is 33, and the minimum amount required for application is ₹14,718.
You can apply in Thyrocare Technologies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Thyrocare Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Thyrocare Technologies IPO allotment status.
The Thyrocare Technologies IPO listing date is on Monday, May 9, 2016.
Useful Articles